289 related articles for article (PubMed ID: 22396496)
1. CD73-deficient mice are resistant to carcinogenesis.
Stagg J; Beavis PA; Divisekera U; Liu MC; Möller A; Darcy PK; Smyth MJ
Cancer Res; 2012 May; 72(9):2190-6. PubMed ID: 22396496
[TBL] [Abstract][Full Text] [Related]
2. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.
Stagg J; Divisekera U; Duret H; Sparwasser T; Teng MW; Darcy PK; Smyth MJ
Cancer Res; 2011 Apr; 71(8):2892-900. PubMed ID: 21292811
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.
Stagg J; Divisekera U; McLaughlin N; Sharkey J; Pommey S; Denoyer D; Dwyer KM; Smyth MJ
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1547-52. PubMed ID: 20080644
[TBL] [Abstract][Full Text] [Related]
4. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.
Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122
[TBL] [Abstract][Full Text] [Related]
5. CD73 plays a protective role in collagen-induced arthritis.
Chrobak P; Charlebois R; Rejtar P; El Bikai R; Allard B; Stagg J
J Immunol; 2015 Mar; 194(6):2487-92. PubMed ID: 25681339
[TBL] [Abstract][Full Text] [Related]
6. Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.
Terp MG; Olesen KA; Arnspang EC; Lund RR; Lagerholm BC; Ditzel HJ; Leth-Larsen R
J Immunol; 2013 Oct; 191(8):4165-73. PubMed ID: 24043904
[TBL] [Abstract][Full Text] [Related]
7. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.
Allard B; Pommey S; Smyth MJ; Stagg J
Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257
[TBL] [Abstract][Full Text] [Related]
8. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
[TBL] [Abstract][Full Text] [Related]
9. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.
Wang L; Fan J; Thompson LF; Zhang Y; Shin T; Curiel TJ; Zhang B
J Clin Invest; 2011 Jun; 121(6):2371-82. PubMed ID: 21537079
[TBL] [Abstract][Full Text] [Related]
10. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.
Yegutkin GG; Marttila-Ichihara F; Karikoski M; Niemelä J; Laurila JP; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2011 May; 41(5):1231-41. PubMed ID: 21469131
[TBL] [Abstract][Full Text] [Related]
11. CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice.
Eichin D; Pessia A; Takeda A; Laakkonen J; Bellmann L; Kankainen M; Imhof BA; Stoitzner P; Tang J; Salmi M; Jalkanen S
Eur J Immunol; 2021 Jan; 51(1):231-246. PubMed ID: 32970335
[TBL] [Abstract][Full Text] [Related]
12. CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
Turcotte M; Allard D; Mittal D; Bareche Y; Buisseret L; José V; Pommey S; Delisle V; Loi S; Joensuu H; Kellokumpu-Lehtinen PL; Sotiriou C; Smyth MJ; Stagg J
Cancer Res; 2017 Oct; 77(20):5652-5663. PubMed ID: 28855210
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease.
Tsukamoto H; Chernogorova P; Ayata K; Gerlach UV; Rughani A; Ritchey JW; Ganesan J; Follo M; Zeiser R; Thompson LF; Idzko M
Blood; 2012 May; 119(19):4554-64. PubMed ID: 22262774
[TBL] [Abstract][Full Text] [Related]
14. Allergen-induced airway hyperresponsiveness is absent in ecto-5'-nucleotidase (CD73)-deficient mice.
Schreiber R; Castrop H; Kunzelmann K
Pflugers Arch; 2008 Nov; 457(2):431-40. PubMed ID: 18607626
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Immunological Effects of CD73 Deficiency.
Adam T; Mathes A; Isayev O; Philippov PP; Werner J; Karakhanova S; Bazhin AV
Cell Physiol Biochem; 2019; 52(5):1192-1202. PubMed ID: 31001959
[TBL] [Abstract][Full Text] [Related]
16. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J
Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451
[TBL] [Abstract][Full Text] [Related]
17. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
Jin D; Fan J; Wang L; Thompson LF; Liu A; Daniel BJ; Shin T; Curiel TJ; Zhang B
Cancer Res; 2010 Mar; 70(6):2245-55. PubMed ID: 20179192
[TBL] [Abstract][Full Text] [Related]
18. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
[TBL] [Abstract][Full Text] [Related]
19. Ecto-5'-Nucleotidase (CD73) Deficiency in Mycobacterium tuberculosis-Infected Mice Enhances Neutrophil Recruitment.
Petit-Jentreau L; Jouvion G; Charles P; Majlessi L; Gicquel B; Tailleux L
Infect Immun; 2015 Sep; 83(9):3666-74. PubMed ID: 26150535
[TBL] [Abstract][Full Text] [Related]
20. The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury.
Kim M; Ham A; Kim JY; Brown KM; D'Agati VD; Lee HT
Kidney Int; 2013 Jul; 84(1):90-103. PubMed ID: 23423261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
